Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Identification of ISG15 and ZFP36 as novel hypoxia- and immune-related gene signatures contributing to a new perspective for the treatment of prostate cancer by bioinformatics and experimental verification

Fig. 3

Validation of the prognostic signature in the MSKCC dataset. A The K–M curves of ISG15 and ZFP36 in the validation dataset. B, C The distribution of risk scores for each patient and the expression of the two prognostic genes in high- and low- risk groups in the validation set. D Kaplan–Meier curve of high- and low-risk groups in the validation set. E ROC curves of 1/3/5 years predictions in the validation set

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us